azacitidine has been researched along with Multiple Primary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nohgawa, M; Oka, S; Ono, K | 1 |
| Deng, AC; Magro, CM; Sagransky, MJ | 1 |
1 review(s) available for azacitidine and Multiple Primary Neoplasms
| Article | Year |
|---|---|
Primary cutaneous langerhans cell sarcoma: a report of four cases and review of the literature.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Decitabine; Humans; Immunophenotyping; Langerhans Cell Sarcoma; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Multiple Primary; Skin Neoplasms | 2013 |
1 other study(ies) available for azacitidine and Multiple Primary Neoplasms
| Article | Year |
|---|---|
Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation.
Topics: Aged; Anemia, Macrocytic; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 5; Disease Progression; Female; Humans; In Situ Hybridization, Fluorescence; Janus Kinase 2; Leukemia, Myeloid, Acute; Multiple Myeloma; Mutation, Missense; Neoplasms, Multiple Primary; Remission Induction; Translocation, Genetic | 2017 |